Abstract
Angiotensin II, through AT1 receptor stimulation, mediates multiple cardiovascular, metabolic, and behavioral functions including the response to stressors. Conversely, the function of Angiotensin II AT2 receptors has not been totally clarified. In adult rodents, AT2 receptor distribution is very limited but it is particularly high in the adrenal medulla. Recent results strongly indicate that AT2 receptors contribute to the regulation of the response to stress stimuli. This occurs in association with AT1 receptors, both receptor types reciprocally influencing their expression and therefore their function. AT2 receptors appear to influence the response to many types of stressors and in all components of the hypothalamic–pituitary–adrenal axis. The molecular mechanisms involved in AT2 receptor activation, the complex interactions with AT1 receptors, and additional factors participating in the control of AT2 receptor regulation and activity in response to stressors are only partially understood. Further research is necessary to close this knowledge gap and to clarify whether AT2 receptor activation may carry the potential of a major translational advance.
Similar content being viewed by others
References
AbdAlla S, Lother H, Quitterer U (2000) AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407:94–98. doi:10.1038/35024095
AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U (2001) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276:39721–39726. doi:10.1074/jbc.M105253200
Akazawa H, Yano M, Yabumoto C, Kudo-Sakamoto Y, Komuro I (2013) Angiotensin II type 1 and type 2 receptor-induced cell signaling. Curr Pharm Des 19:2988–2995. doi:10.2174/1381612811319170003
Aldred GP, Chai SY, Song K, Zhuo J, MacGregor DP, Mendelsohn FA (1993) Distribution of angiotensin II receptor subtypes in the rabbit brain. Regul Pept 44:119–130
Alhusban A, Fouda AY, Pillai B, Ishrat T, Soliman S, Fagan SC (2015) Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic stroke. J Hypertens 33:170–180. doi:10.1097/HJH.0000000000000364
Allen AM, MacGregor DP, McKinley MJ, Mendelsohn FA (1999) Angiotensin II receptors in the human brain. Regul Pept 79:1–7. doi:10.1016/S0167-0115(98)00138-4
Armando I, Carranza A, Nishimura Y, Hoe KL, Barontini M, Terrón JA, Falcón-Neri A, Ito T, Juorio AV, Saavedra JM (2001) Peripheral administration of an angiotensin II AT(1) receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress. Endocrinology 142:3880–3889. doi:10.1210/endo.142.9.8366
Armando I, Jezova M, Juorio AV, Terrón JA, Falcón-Neri A, Semino-Mora C, Imboden H, Saavedra JM (2002a) Estrogen upregulates renal angiotensin II AT2 receptors. Am J Physiol Renal Physiol 283:F934–F943. doi:10.1152/ajprenal.00145.2002
Armando I, Terrón JA, Falcón-Neri A, Takeshi I, Häuser W, Inagami T, Saavedra JM (2002b) Increased angiotensin II AT(1) receptor expression in paraventricular nucleus and hypothalamic-pituitary-adrenal axis stimulation in AT(2) receptor gene disrupted mice. Neuroendocrinology 76:137–147. doi:10.1159/000064525
Armando I, Seltzer A, Bregonzio C, Saavedra JM (2003a) Stress and angiotensin II: novel therapeutic opportunities. Curr Drug Targets CNS Neurol Disord 2:413–419
Armando I, Tjurmina OA, Li Q, Murphy DL, Saavedra JM (2003b) The serotonin transporter is required for stress-evoked increases in adrenal catecholamine synthesis and angiotensin II AT(2) receptor expression. Neuroendocrinology 78:217–225. Erratum in Neuroendocrinology. 2003; 78(5):252. doi:10.1159/000073705
Armando I, Jezova M, Bregonzio C, Baiardi G, Saavedra JM (2004) Angiotensin II AT1 and AT2 receptor types regulate basal and stress-induced adrenomedullary catecholamine production through transcriptional regulation of tyrosine hydroxylase. Ann N Y Acad Sci 1018:302–309. doi:10.1196/annals.1296.036
Bądzyńska B, Lipkowski AW, Sadowski J, Kompanowska-Jezierska E (2014) Vascular effects of a tripeptide fragment of novokinine in hypertensive rats: Mechanism of the hypotensive action. Pharmacol Rep 66:856–861. doi:10.1016/j.pharep.2014.04.013
Baiardi G, Macova M, Armando I, Ando H, Tyurmin D, Saavedra JM (2005) Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat. Regul Pept 124:7–17. doi:10.1016/j.regpep.2004.06.021
Bali A, Jaggi AS (2013) Angiotensin as stress mediator: role of its receptor and interrelationships among other stress mediators and receptors. Pharmacol Res 76:49–57. doi:10.1016/j.phrs.2013.07.004
Balla T, Baukal AJ, Eng S, Catt KJ (1991) Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Mol Pharmacol 40:401–406
Baptista RF, Chies AB, Taipeiro EF, Cordellini S (2014) Endothelial AT1 and AT2 pathways in aortic responses to angiotensin II after stress and ethanol consumption in rats. Stress 17:512–519. doi:10.3109/10253890.2014.966262
Batenburg WW, Danser AH (2012) (Pro)renin and its receptors: pathophysiological implications. Clin Sci (Lond) 123:121–133. doi:10.1042/CS20120042
Belloni AS, Andreis PG, Macchi V, Gottardo G, Malendowicz LK, Nussdorfer GG (1998) Distribution and functional significance of angiotensin-II AT1- and AT2-receptor subtypes in the rat adrenal gland. Endocr Res 24:1–15
Benicky J, Hafko R, Sanchez-Lemus E, Aguilera G, Saavedra JM (2012) Six commercially available angiotensin II AT1 receptor antibodies are non-specific. Cell Mol Neurobiol 32:1353–1365. doi:10.1007/s10571-012-9862-y
Bibeau K, Battista MC, Houde V, Brochu M (2010) Fetal adrenal gland alterations in a rat model of adverse intrauterine environment. Am J Physiol Regul Integr Comp Physiol 298:R899–R911. doi:10.1152/ajpregu.00238.2009
Blankley CJ, Hodges JC, Klutchko SR, Himmelsbach RJ, Chucholowski A, Connolly CJ, Neergaard SJ, Van Nieuwenhze MS, Sebastian A, Quin J 3rd et al (1991) Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. J Med Chem 34:3248–3260
Bobrovskaya L, Maniam J, Ong LK, Dunkley PR, Morris MJ (2013) Early life stress and post-weaning high fat diet alter tyrosine hydroxylase regulation and AT1 receptor expression in the adrenal gland in a sex dependent manner. Neurochem Res 38:826–833. . doi:10.1007/s11064-013-0985-4
Bollag WB (2014) Regulation of aldosterone synthesis and secretion. Compr Physiol 4:1017–1055. doi:10.1002/cphy.c130037
Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J, Anagnostou V, Rimm D (2010) Antibody validation. Biotechniques 48:197–209. Erratum in: Biotechniques. 2010; 48:351. doi:10.2144/000113382
Bossé R, Servant G, Zhou LM, Boulay G, Guillemette G, Escher E (1993) Sar1-p-benzoylphenylalanine-angiotensin, a new photoaffinity probe for selective labeling of the type 2 angiotensin receptor. Regul Pept 44:215–223
Bottari SP, Taylor V, King IN, Bogdal Y, Whitebread S, de Gasparo M (1991) Angiotensin II AT2 receptors do not interact with guanine nucleotide binding proteins. Eur J Pharmacol 207:157–163
Bottari SP, King IN, Reichlin S, Dahlstroem I, Lydon N, de Gasparo M (1992) The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem Biophys Res Commun 183:206–211. 10.1016/0006-291X(92)91629-5
Brechler V, Levens NR, De Gasparo M, Bottari SP (1994a) Angiotensin AT2 receptor mediated inhibition of particulate guanylate cyclase: a link with protein tyrosine phosphatase stimulation? Recept Channels 2:79–87
Brechler V, Reichlin S, De Gasparo M, Bottari SP (1994b) Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism. Recept Channels 2:89–98
Bregonzio C, Armando I, Ando H, Jezova M, Baiardi G, Saavedra JM (2003) Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol 285:G414–G423. doi:10.1152/ajpgi.00058.2003
Bregonzio C, Seltzer A, Armando I, Pavel J, Saavedra JM (2008) Angiotensin II AT(1) receptor blockade selectively enhances brain AT(2) receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats. Stress 11:457–466. Erratum in: Stress. 2009; 12:95. doi:10.1080/10253890801892040
Brosnihan KB, Hodgin JB, Smithies O, Maeda N, Gallagher P (2008) Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by estrogen in ApoE/ERa knockout mice. Exp Physiol 93:658–664. doi:10.1113/expphysiol.2007.041806
Bucher M, Hobbhahn J, Kurtz A (2001) Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit Care Med 29:1750–1755
Carney EF (2015) Hypertension: new non RAS peptide modulates the vasoregulatory effects of angiotensin II. Nat Rev Nephrol 11:317. doi:10.1038/nrneph.2015.52
Carrasco GA, Van de Kar LD (2003) Neuroendocrine pharmacology of stress. Eur J Pharmacol 463:235–272. doi:10.1016/S0014-2999(03)01285-8
Castiñeiras-Landeira MI, Rodiño-Janeiro BK, Paradela-Dobarro Batista-Oliveira AL, Raposeiras-Roubín S, González-Peteiro M, González-Juanatey JR, Álvarez E (2016) Change of concept about the regulation of angiotensin II-induced monocyte chemoattractant protein-1 production in human endothelial cells. Vasc Pharmacol 80:20–34. doi:10.1016/j.vph.2015.12.003
Castoldi G, di Gioia CR, Bombardi C, Maestroni S, Carletti R, Steckelings UM, Dahlöf B, Unger T, Zerbini G, Stella A (2014) Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats. Am J Physiol Renal Physiol 307:F1123–F1131. doi:10.1152/ajprenal.00247.2014
Chang RS, Lotti VJ (1991) Angiotensin receptor subtypes in rat, rabbit and monkey tissues: relative distribution and species dependency. Life Sci 49:1485–1490
Chatelain D, Montel V, Dickes-Coopman A, Chatelain A, Deloof S (2003) Trophic and steroidogenic effects of water deprivation on the adrenal gland of the adult female rat. Regul Pept 110:249–255. doi:10.1016/S0167-0115(02)00217-3
Chiu AT, McCall DE, Ardecky RJ, Duncia JV, Nguyen TT, Timmermans PB (1990-1991) Angiotensin II receptor subtypes and their selective nonpeptide ligands. Receptor 1:33–40
Chow BS, Koulis C, Krishnaswamy P, Steckelings UM, Unger T, Cooper ME, Jandeleit-Dahm KA, Allen TJ (2016) The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis. Diabetologia 59:1778–1790. doi:10.1007/s00125-016-3977-5
Chrousos GP, Gold PW (1992) The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267:1244–252. Erratum in: JAMA 1992;268:200.doi:10.1001/jama.1992.03480090092034
Chung O, Unger T (1999) Angiotensin II receptor blockade and end-organ protection. Am J Hypertens 12:150S–156S
Ciuffo GM, Saavedra JM (1995) Selective peptide and nonpeptide ligands differentially bind to angiotensin II AT2 receptor and a non-angiotensin II CGP42112 binding site. J Pharmacol Exp Ther 274:1129–1134
Clauser E, Curnow KM, Davies E, Conchon S, Teutsch B, Vianello B, Monnot C, Corvol P (1996) Angiotensin II receptors: protein and gene structures, expression and potential pathological involvements. Eur J Endocrinol 134:403–411
Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G, Volpe M (2005) Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am J Hypertens 18:493–499. doi:10.1016/j.amjhyper.2004.11.007
Danser AH, Slump DE, Grefhorst A, van Veghel R, Garrelds IM, Roks AJ, Kushner SA, van Esch JH (2015) 8D.06: angiotensin II type 2 receptor- and acetylcholine-mediated relaxation: the essential contribution of female sex hormones and chromosomes. J Hypertens 33(Suppl 1):e115. doi:10.1097/01.hjh.0000467660.69156.d5
de Gasparo M, Siragy HM (1999) The AT2 receptor: fact, fancy and fantasy. Regul Pept 81:11–24
de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415–472
de Oliveira AM, Viswanathan M, Heemskerk FM, Correa FM, Saavedra JM (1994) Specific, non-angiotensin, [125I]CGP 42112 binding sites in rat spleen macrophages. Biochem Biophys Res Commun 200:1049–1058. doi:10.1006/bbrc.1994.1556
Defaye G, Lecomte S, Chambaz EM, Bottari SP (1995) Stimulation of cortisol production through angiotensin AT2 receptors in bovine fasciculata cells. Endocr Res 21:183–187
Egidy G, Friedman J, Viswanathan M, Wahl LM, Saavedra JM (1997) CGP-42112 partially activates human monocytes and reduces their stimulation by lipopolysaccharides. Am J Physiol 273:C826–C833
El Muayed M, Stegbauer J, Oberhauser V, Vonend O, Rump LC (2004) AT1 and AT2-receptor antagonists inhibit Ang II-mediated facilitation of noradrenaline release in human atria. J Cardiovasc Pharmacol 43:318–324
Elijovich F, Zhao HW, Laffer CL, Du Y, DiPette DJ, Inagami T, Wang DH (1997) Regulation of growth of the adrenal gland in DOC-salt hypertension. Role of angiotensin II receptor subtypes. Hypertension 29:408–413. doi:10.1161/01.HYP.29.1.408
Ferrario CM, Ahmad S, Nagata S, Simington SW, Varagic J, Kon N (2014) Dell’italia LJ. An evolving story of angiotensin-II-forming pathways in rodents and humans. Clin Sci (Lond) 126:461–469. doi:10.1042/CS20130400
Forcier I, St-Louis J, Brochu M (1995) Angiotensin II receptor subtypes in the adrenals of pregnant rats. Mol Cell Endocrinol 114:177–186
Fouda AY, Pillai B, Dhandapani KM, Ergul A, Fagan SC (2017) Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injury. Eur J Pharmacol 799:128–134. doi:10.1016/j.ejphar.2017.02.016
Frei N, Weissenberger J, Beck-Sickinger AG, Höfliger M, Weis J, Imboden H (2001) Immunocytochemical localization of angiotensin II receptor subtypes and angiotensin II with monoclonal antibodies in the rat adrenal gland. Regul Pept 101:149–155. doi:10.1016/S0167-0115(01)00278-6
Gao J, Zucker IH, Gao L (2014) Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure. Am J Hypertens 27:1248–1256. doi:110.1093/ajh/hpu044
Gauthier KM, Zhang DX, Edwards EM, Holmes B, Campbell WB (2005) Angiotensin II dilates bovine adrenal cortical arterioles: role of endothelial nitric oxide. Endocrinology 146:3319–3324. doi:10.1210/en.2005-0129
Gelband CH, Sumners C, Lu D, Raizada MK (1998) Angiotensin receptors and norepinephrine neuromodulation: implications of functional coupling. Regul Pept 73:141–147. doi:10.1016/S0167-0115(97)11050-3
Giacchetti G, Opocher G, Sarzani R, Rappelli A, Mantero F (1996) Angiotensin II and the adrenal. Clin Exp Pharmacol Physiol Suppl 3:S119–S124
Gigante B, Rubattu S, Russo R, Porcellini A, Enea I, De Paolis P, Savoia C, Natale A, Piras O, Volpe M (1997) Opposite feedback control of renin and aldosterone biosynthesis in the adrenal cortex by angiotensin II AT1-subtype receptors. Hypertension 30:563–568. doi:10.1161/01.HYP.30.3.563
Gong WK, Lü J, Wang F, Wang B, Wang MY, Huang HP (2015) Effects of angiotensin type 2 receptor on secretion of the locus coeruleus in stress-induced hypertension rats. Brain Res Bull 111:62–68. doi:10.1016/j.brainresbull.2014.12.011
Gradus JL, Farkas DK, Svensson E, Ehrenstein V, Lash TL, Milstein A, Adler N, Sørensen HT (2015) Associations between stress disorders and cardiovascular disease events in the Danish population. BMJ Open 5(12):e009334. doi:10.1136/bmjopen-2015-009334
Gupta P, Franco-Saenz R, Mulrow PJ (1995) Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin-, and potassium-stimulated aldosterone secretion. Hypertension 25:443–448. doi:10.1161/01.HYP.25.3.443
Guthrie GP Jr (1995) Angiotensin receptors: physiology and pharmacology. Clin Cardiol 18:29–34
Hafko R, Villapol S, Nostramo R, Symes A, Sabban EL, Inagami T, Saavedra JM (2013) Commercially available angiotensin II At2 receptor antibodies are nonspecific. PLoS ONE 8:e69234. doi:10.1371/journal.pone.0069234
Hano T, Mizukoshi M, Baba A, Nakamura N, Nishio I (1994) Angiotensin II subtype 1 receptor modulates epinephrine release from isolated rat adrenal gland. Blood Press Suppl 5:105–108
Hansen JL, Hansen JT, Speerschneider T, Lyngsø C, Erikstrup N, Burstein ES, Weiner DM, Walther T, Makita N, Iiri T, Merten N, Kostenis E, Sheikh SP (2009) Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer? J Biol Chem 284:1831–1839. doi:10.1074/jbc.M804607200
Häuser W, Jöhren O, Saavedra JM (1998) Characterization and distribution of angiotensin II receptor subtypes in the mouse brain. Eur J Pharmacol 348:101–114. doi:10.1016/S0014-2999(98)00134-4
Heemskerk FM, Saavedra JM (1995) Quantitative autoradiography of angiotensin II AT2 receptors with [125I] CGP 42112. Brain Res 677:29–38. doi:10.1016/0006-8993(95)00092-5
Heemskerk FM, Zorad S, Seltzer A, Saavedra JM (1993) Characterization of brain angiotensin II AT2 receptor subtype using [125I] CGP 42112A. NeuroReport 4:103–105
Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK (1995) Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377:744–747. Erratum in: Nature 1996;380:366. doi:10.1038/377744a0
Herrera M, Sparks MA, Alfonso-Pecchio AR, Harrison-Bernard LM, Coffman TM (2013) Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein. Hypertension 61:253–258. doi:10.1161/HYPERTENSIONAHA.112.203679
Himeno A, Nazarali AJ, Saavedra JM (1988) Quantitative in vitro autoradiographic characterization of [125I]angiotensin III binding sites in rat adrenal gland. Regul Pept 23:127–133. doi:10.1016/0167-0115(88)90020-1
Horiba N, Nomura K, Shizume K (1990) Exogenous and locally synthesized angiotensin II and glomerulosa cell functions. Hypertension 15:190–197. doi:10.1161/01.HYP.15.2.190
Horiuchi M, Iwanami J, Mogi M (2012) Regulation of angiotensin II receptors beyond the classical pathway. Clin Sci (Lond) 123:193–203. doi:10.1042/CS20110677
Hunyady L, Catt KJ (2006) Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 20:953–970. doi:10.1210/me.2004-0536
Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T (1995) Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377:748–750
Inagami T, Guo DF, Kitami Y (1994) Molecular biology of angiotensin II receptors: and overview. J Hypertens Suppl 12:S83–S94
Inagami T, Yamano Y, Bardhan S, Chaki S, Guo DF, Ohyama K, Kambayashi Y, Takahashi K, Ichiki T, Tsuzuki S et al (1995) Cloning, expression and regulation of angiotensin II receptors. Adv Exp Med Biol 377:311–317
Ishii K, Takekoshi K, Shibuya S, Kawakami Y, Isobe K, Nakai T (2001) Angiotensin subtype-2 receptor (AT2) negatively regulates subtype-1 receptor (AT1) in signal transduction pathways in cultured porcine adrenal medullary chromaffin cells. J Hypertens 19:1991–1999
Ising M, Holsboer F (2006) Genetics of stress response and stress-related disorders. Dialogues Clin Neurosci 8:433–444
Israel A, Correa FM, Niwa M, Saavedra JM (1984) Quantitative measurement of angiotensin II (A II) receptors in discrete regions of rat brain, pituitary and adrenal gland by autoradiography. Clin Exp Hypertens A 6:1761–1764
Israel A, Niwa M, Plunkett LM, Saavedra JM (1985a) High-affinity angiotensin receptors in rat adrenal medulla. Regul Pept 11:237–243. doi:10.1016/0167-0115(85)90055-2
Israel A, Plunkett LM, Saavedra JM (1985b) Quantitative autoradiographic characterization of receptors for angiotensin II and other neuropeptides in individual brain nuclei and peripheral tissues from single rats. Cell Mol Neurobiol 5:211–222
Israel A, Strömberg C, Tsutsumi K, Garrido MR, Torres M, Saavedra JM (1995) Angiotensin II receptor subtypes and phosphoinositide hydrolysis in rat adrenal medulla. Brain Res Bull 38:441–446. doi:10.1016/0361-9230(95)02011-F
Iwanami J, Mogi M, Tsukuda K, Jing F, Ohshima K, Wang XL, Nakaoka H, Kan-no H, Chisaka T, Bai HY, Min LJ, Horiuchi M (2014) Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on prevention of cognitive decline in type 2 diabetic mice. Eur J Pharmacol 724:9–15. doi:10.1016/j.ejphar.2013.12.015
Iwanami J, Mogi M, Tsukuda K, Wang XL, Nakaoka H, Kan-no H, Chisaka T, Bai HY, Shan BS, Kukida M, Horiuchi M (2015) Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia. J Am Soc Hypertens 9:250–256. doi:10.1016/j.jash.2015.01.010
Jain P, Armando I, Juorio AV, Barden N, Benicky J, Saavedra JM (2004) Decreased hypothalamic and adrenal angiotensin II receptor expression and adrenomedullary catecholamines in transgenic mice with impaired glucocorticoid receptor function. Neuroendocrinology 80:171–180. doi:10.1159/000082358
Jezova M, Armando I, Bregonzio C, Yu ZX, Qian S, Ferrans VJ, Imboden H, Saavedra JM (2003) Angiotensin II AT(1) and AT(2) receptors contribute to maintain basal adrenomedullary norepinephrine synthesis and tyrosine hydroxylase transcription. Endocrinology 144:2092–2101. doi:10.1210/en.2002-0019
Jöhren O, Saavedra JM (1996) Gene expression of angiotensin II receptor subtypes in the cerebellar cortex of young rats. NeuroReport 7:1349–1352
Jöhren O, Inagami T, Saavedra JM (1995a) AT1A, AT1B, and AT2 angiotensin II receptor subtype gene expression in rat brain. NeuroReport 6:2549–2552
Jöhren O, Viswanathan M, Saavedra JM (1995b) Expression of non-angiotensin II -125I-CGP 42112 binding sites on activated microglia after kainic acid induced neurodegeneration. Brain Res 702:153–161. doi:10.1016/0006-8993(95)01035-3
Jöhren O, Inagami T, Saavedra JM (1996) Localization of AT2 angiotensin II receptor gene expression in rat brain by in situ hybridization histochemistry. Brain Res Mol Brain Res 37:192–200
Jöhren O, Imboden H, Häuser W, Maye I, Sanvitto GL, Saavedra JM (1997) Localization of angiotensin-converting enzyme, angiotensin II, angiotensin II receptor subtypes, and vasopressin in the mouse hypothalamus. Brain Res 757:218–227. doi:10.1016/S0006-8993(97)00220-5
Jöhren O, Golsch C, Dendorfer A, Qadri F, Häuser W, Dominiak P (2003) Differential expression of AT1 receptors in the pituitary and adrenal gland of SHR and WKY. Hypertension 41:984–990. doi:10.1161/01.HYP.0000062466.38314.B7
Joseph JP, Mecca AP, Regenhardt RW, Bennion DM, Rodríguez V, Desland F, Patel NA, Pioquinto DJ, Unger T, Katovich MJ, Steckelings UM, Sumners C (2014) The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke. Neuropharmacology 81:134–141. doi:10.1016/j.neuropharm.2014.01.044
Jugdutt BI (2015) Expanding saga of the renin-angiotensin system: the angiotensin ii counter-regulatory At2 receptor pathway. Circulation 131:1380–1383. doi:10.1161/CIRCULATIONAHA.115.016328
Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T (1993) Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 268:24543–24546
Kambayashi Y, Nagata K, Ichiki T, Inagami T (1996) Insulin and insulin-like growth factors induce expression of angiotensin type-2 receptor in vascular-smooth-muscle cells. Eur J Biochem 239:558–565. doi:10.1111/j.1432-1033.1996.0558u.x
Karnik SS, Unal H, Kemp JR, Tirupula KC, Eguchi S, Vanderheyden PM, Thomas WG (2015) International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin receptors: interpreters of pathophysiological angiotensinergic stimuli [corrected]. Pharmacol Rev 67:754–819. Erratum in: Pharmacol Rev. 2015;67:820. doi:10.1124/pr.114.010454
Kijima K, Matsubara H, Murasawa S, Maruyama K, Ohkubo N, Mori Y, Inada M (1996) Regulation of angiotensin II type 2 receptor gene by the protein kinase C-calcium pathway. Hypertension 27:529–534. doi:10.1161/01.HYP.27.3.529
Kitamura Y, Sasamura H, Nakaya H, Maruyama T, Hayashi M, Saruta T (1998) Effects of ACTH on adrenal angiotensin II receptor subtype expression in vivo. Mol Cell Endocrinol 146:187–195
Kumar R, Thomas CM, Yong QC, Chen W, Baker KM (2012) The intracrine renin-angiotensin system. Clin Sci (Lond) 123:273–284. doi:10.1042/CS20120089
Laredo J, Shah JR, Lu ZR, Hamilton BP, Hamlyn JM (1997) Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension 29:401–407. doi:10.1161/01.HYP.29.1.401
Lebrethon MC, Naville D, Begeot M, Saez JM (1994) Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II. J Clin Investig 93:1828–1833. doi:110.1172/JCI117168
Lefebvre H, Contesse V, Delarue C, Vaudry H, Kuhn JM (1998) Serotonergic regulation of adrenocortical function. Horm Metab Res 30:398–403. doi:10.1055/s-2007-978904
Lehoux JG, Bird IM, Briere N, Martel D, Ducharme L (1997) Influence of dietary sodium restriction on angiotensin II receptors in rat adrenals. Endocrinology 138:5238–5247. doi:10.1210/endo.138.12.5612
Leong DS, Terrón JA, Falcón-Neri A, Armando I, Ito T, Jöhren O, Tonelli LH, Hoe KL, Saavedra JM (2002) Restraint stress modulates brain, pituitary and adrenal expression of angiotensin II AT(1A), AT(1B) and AT(2) receptors. Neuroendocrinology 75:227–240. doi:10.1159/000054714
Li Y, Saito Y, Kuwahara K, Rong X, Kishimoto I, Harada M, Adachi Y, Nakanishi M, Kinoshita H, Horiuchi M, Murray M, Nakao K (2009) Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart. Endocrinology 150:3759–3765. doi:10.1210/en.2008-1353
Liakos P, Bourmeyster N, Defaye G, Chambaz EM, Bottari SP (1997) ANG II AT1 and AT2 receptors both inhibit bFGF-induced proliferation of bovine adrenocortical cells. Am J Physiol 273:C1324–C1334
Lunardelli A, Luft C, Pedrazza L, Martha BA, de Oliveira JR, Donadio MV (2015) Effects of neonatal inflammation on the inflammatory and oxidative profile during experimental sepsis in adult life. Physiol Behav 151:516–524. doi:10.1016/j.physbeh.2015.08.023
MacGregor DP, Murone C, Song K, Allen AM, Paxinos G, Mendelsohn FA (1995) Angiotensin II receptor subtypes in the human central nervous system. Brain Res 675:231–240. doi:10.1016/0006-8993(95)00076-3
Macova M, Armando I, Zhou J, Baiardi G, Tyurmin D, Larrayoz-Roldan IM, Saavedra JM (2008) Estrogen reduces aldosterone, upregulates adrenal angiotensin II AT2 receptors and normalizes adrenomedullary Fra-2 in ovariectomized rats. Neuroendocrinology 88:276–286. doi:10.1159/000150977
Macova M, Pavel J, Saavedra JM (2009) A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH. Brain Res 23(1250):130–140. doi:10.1016/j.brainres.2008.11.006
Mancina R, Susini T, Renzetti A, Forti G, Razzoli E, Serio M, Maggi M (1996) Sex steroid modulation of AT2 receptors in human myometrium. J Clin Endocrinol Metab 81:1753–1757. doi:10.1016/j.brainres.2008.11.006
Marchant C, Brown L, Sernia C (1993) Renin-angiotensin system in thyroid dysfunction in rats. J Cardiovasc Pharmacol 22:449–455
Martineau D, Lamouche S, Briand R, Yamaguchi N (1999) Functional involvement of angiotensin AT2 receptor in adrenal catecholamine secretion in vivo. Can J Physiol Pharmacol 77:367–374
Mazza R, Imbrogno S, Tota B (2010) The interplay between chromogranin A-derived peptides and cardiac natriuretic peptides in cardioprotection against catecholamine-evoked stress. Regul Pept 165:86–94. doi:10.1016/j.regpep.2010.05.005
Mazzocchi G, Malendowicz LK, Gottardo G, Rebuffat P, Nussdorfer GG (1997) Angiotensin-II stimulates DNA synthesis in rat adrenal zona glomerulosa cells: receptor subtypes involved and possible signal transduction mechanism. Endocr Res 23:191–203
Mazzocchi G, Gottardo G, Macchi V, Malendowicz LK, Nussdorfer GG (1998) The AT2 receptor-mediated stimulation of adrenal catecholamine release may potentiate the AT1 receptor-mediated aldosterone secretagogue action of angiotensin-II in rats. Endocr Res 24:17–28
McCarthy CA, Vinh A, Miller AA, Hallberg A, Alterman M, Callaway JK, Widdop RE (2014) Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats. PLoS ONE 9(4):e95762. doi:10.1371/journal.pone.0095762
Miura S, Imaizumi S, Saku K (2013) Recent progress in molecular mechanisms of angiotensin II type 1 and 2 receptors. Curr Pharm Des 19:2981–2987. doi:10.2174/1381612811319170002
Moser M (1986) Historical perspective on the management of hypertension. Am J Med 80:1–11
Müller H, Kröger J, Jöhren O, Szymczak S, Bader M, Dominiak P, Raasch W (2010) Stress sensitivity is increased in transgenic rats with low brain angiotensinogen. J Endocrinol 204:85–92. doi:10.1677/JOE-09-0363
Murasawa S, Matsubara H, Kijima K, Maruyama K, Ohkubo N, Mori Y, Iwasaka T, Inada M (1996) Down-regulation by cAMP of angiotensin II type 2 receptor gene expression in PC12 cells. Hypertens Res 19:271–279. doi:10.1291/hypres.19.271
Narayanaswami V, Somkuwar SS, Horton DB, Cassis LA, Dwoskin LP (2013) Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [³H]dopamine and [³H]norepinephrine release. Biochem Pharmacol 86:656–665. doi:10.1016/j.bcp.2013.06.025
Nostramo R, Tillinger A, Saavedra JM, Kumar A, Pandey V, Serova L, Kvetnansky R, Sabban EL (2012) Regulation of angiotensin II type 2 receptor gene expression in the adrenal medulla by acute and repeated immobilization stress. J Endocrinol 215:291–301. doi:10.1530/JOE-12-0181
Nostramo R, Serova L, Laukova M, Tillinger A, Peddu C, Sabban EL (2015) Regulation of nonclassical renin-angiotensin system receptor gene expression in the adrenal medulla by acute and repeated immobilization stress. Am J Physiol Regul Integr Comp Physiol 308:R517–R529. doi:10.1152/ajpregu.00130.2014
Obermüller N, Schlamp D, Hoffmann S, Gentili M, Inagami T, Gretz N, Weigel M (1998) Localization of the mRNA for the angiotensin II receptor subtype 2 (AT2) in follicular granulosa cells of the rat ovary by nonradioactive in situ hybridization. J Histochem Cytochem 46:865–870. doi:10.1177/002215549804600801
Okamura T, Clemens DL, Inagami T (1984) Generation of angiotensins in cultured pheochromocytoma cells. Neurosci Lett 46:151–156
Okuyama S, Sakagawa T, Chaki S, Imagawa Y, Ichiki T, Inagami T (1999) Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor. Brain Res 821:150–159. doi:10.1016/S0006-8993(99)01098-7
Ouali R, Berthelon MC, Bégeot M, Saez JM (1997) Angiotensin II receptor subtypes AT1 and AT2 are down-regulated by angiotensin II through AT1 receptor by different mechanisms. Endocrinology 138:725–733. doi:10.1210/endo.138.2.4952
Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM (1997) Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30:1238–1246. doi:10.1161/01.HYP.30.5.1238
Pavel J, Terrón JA, Benicky J, Falcón-Neri A, Rachakonda A, Inagami T, Saavedra JM (2009) Increased angiotensin II AT1 receptor mRNA and binding in spleen and lung of AT2 receptor gene disrupted mice. Regul Pept 158:156–166. doi:10.1016/j.regpep.2009.09.004
Peng H, Myers J, Fang X, Stachowiak EK, Maher PA, Martins GG, Popescu G, Berezney R, Stachowiak MK (2002) Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C. J Neurochem 81:506–524. doi:10.1046/j.1471-4159.2002.00833.x
Peters J (2012) Local renin-angiotensin systems in the adrenal gland. Peptides 34:427–432. doi:10.1016/j.peptides.2012.01.023
Porrello ER, Delbridge LM, Thomas WG (2009) The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor. Front Biosci (Landmark Ed). 14:958–972
Premer C, Lamondin C, Mitzey A, Speth RC, Brownfield MS (2013) Immunohistochemical localization of AT1a, AT1b, and AT2 angiotensin II receptor subtypes in the rat adrenal, pituitary, and brain with a perspective commentary. Int J Hypertens 2013:175428. doi:10.1155/2013/175428
Pucell AG, Hodges JC, Sen I, Bumpus FM, Husain A (1991) Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor. Endocrinology 128:1947–1959. doi:10.1210/endo-128-4-1947
Qiu J, Nelson SH, Speth RC, Wang DH (1999) Regulation of adrenal angiotensin receptor subtypes: a possible mechanism for sympathectomy-induced adrenal hypertrophy. J Hypertens 17:933–940
Reagan LP, Sakai RR, Fluharty SJ (1996) Immunological analysis of angiotensin AT2 receptors in peripheral tissues of neonatal and adult rats. Regul Pept 65:159–164. doi:10.1016/0167-0115(96)00087-0
Roulston CL, Lawrence AJ, Jarrott B, Widdop RE (2004) Non-angiotensin II [(125)I] CGP42112 binding is a sensitive marker of neuronal injury in brainstem following unilateral nodose ganglionectomy: comparison with markers for activated microglia. Neuroscience 127:753–767. doi:10.1016/j.neuroscience.2004.04.062
Saavedra JM (1992) Brain and pituitary angiotensin. Endocr Rev 13:329–380. doi:10.1210/edrv-13-2-329
Saavedra JM (2005) Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 25:485–512. doi:10.1007/s10571-005-4011-5
Saavedra JM (2012) Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clin Sci (Lond) 123:567–590. doi:10.1042/CS20120078
Saavedra JM (2016) Evidence to consider angiotensin II receptor blockers for the treatment of early Alzheimer's disease. Cell Mol Neurobiol 36:259–279. doi:10.1007/s10571-015-0327-y
Saavedra JM, Benicky J (2007) Brain and peripheral angiotensin II play a major role in stress. Stress 10:185–193. doi:10.1080/10253890701350735
Saavedra JM, Pavel J (2006) The discovery of a novel macrophage binding site. Cell Mol Neurobiol 26:509–526. doi:10.1007/s10571-006-9044-x
Saavedra JM, Armando I, Terrón JA, Falcón-Neri A, Jöhren O, Häuser W, Inagami T (2001a) Increased AT(1) receptors in adrenal gland of AT(2) receptor gene-disrupted mice. Regul Pept 102:41–47. doi:10.1016/S0167-0115(01)00303-2
Saavedra JM, Häuser W, Ciuffo G, Egidy G, Hoe KL, Jöhren O, Sembonmatsu T, Inagami T, Armando I (2001b) Increased AT(1) receptor expression and mRNA in kidney glomeruli of AT(2) receptor gene-disrupted mice. Am J Physiol Renal Physiol 280:F71–F78
Saavedra JM, Ando H, Armando I, Baiardi G, Bregonzio C, Jezova M, Zhou J (2004) Brain angiotensin II, an important stress hormone: regulatory sites and therapeutic opportunities. Ann N Y Acad Sci 1018:76–84. doi:10.1196/annals.1296.009
Saavedra JM, Armando I, Bregonzio C, Juorio A, Macova M, Pavel J, Sanchez-Lemus E (2006) A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding. Neuropsychopharmacology 31:1123–1134
Saavedra JM, Sánchez-Lemus E, Benicky J (2011) Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoneuroendocrinology 36:1–18. doi:10.1016/j.psyneuen.2010.10.001
Saito M, Shinohara Y, Sasaki H, Netsu Y, Yoshida M, Nakahata N (2008) Type 1 angiotensin receptor (AT1-R)-mediated decrease in type 2 angiotensin receptor mRNA level is dependent on Gq and extracellular signal-regulated kinase 1//2 in AT1-R-transfected PC12 cells. J Neuroendocrinol 20:299–308. doi:10.1111/j.1365-2826.2008.01646.x
Sala F, Nistri A, Criado M (2008) Nicotinic acetylcholine receptors of adrenal chromaffin cells. Acta Physiol (Oxf) 192:203–212. doi:10.1111/j.1748-1716.2007.01804.x
Salem S, Jankowski V, Asare Y, Liehn E, Welker P, Raya-Bermudez A, Pineda-Martos C, Rodriguez M, Muñoz-Castañeda JR, Bruck H, Marx N, Machado FB, Staudt M, Heinze G, Zidek W, Jankowski J (2015) Identification of the vasoconstriction-inhibiting factor (VIF), a potent endogenous cofactor of angiotensin II acting on the angiotensin II type 2 receptor. Circulation 131:1426–1434. doi:10.1161/CIRCULATIONAHA.114.013168
Sampson AK, Irvine JC, Shihata WA, Dragoljevic D, Lumsden N, Huet O, Barnes T, Unger T, Steckelings UM, Jennings GL, Widdop RE, Chin-Dusting JP (2016) Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo. Br J Pharmacol 173:729–740. doi:10.1111/bph.13063
Sanchez-Lemus E, Murakami Y, Larrayoz-Roldan IM, Moughamian AJ, Pavel J, Nishioku T, Saavedra JM (2008) Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland. Endocrinology 149:5177–5188. doi:10.1210/en.2008-0242
Saper CB (2009) A guide to the perplexed on the specificity of antibodies. J Histochem Cytochem 57:1–5. doi:10.1369/jhc.2008.952770
Saper CB, Sawchenko PE (2003) Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol 465:161–163. doi:10.1002/cne.10858
Saylor DL, Perez RA, Absher DR, Baisden RH, Woodruff ML, Joyner WL, Rowe BP (1992) Angiotensin II binding sites in the hamster brain: localization and subtype distribution. Brain Res 595:98–106. doi:10.1016/0006-8993(92)91457-P
Seltzer A, Bregonzio C, Armando I, Baiardi G, Saavedra JM (2004) Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats. Brain Res 1028:9–1018. doi:10.1016/j.brainres.2004.06.079
Servant G, Boulay G, Bossé R, Escher E, Guillemette G (1993) Photoaffinity labeling of subtype 2 angiotensin receptor of human myometrium. Mol Pharmacol 43:677–683
Shibata K, Ikuko M, Inoue K, Katsuragi T (1998) Muscarinic acetylcholine receptor-mediated increase of angiotensin type 2 receptor mRNA in PC12 cells. NeuroReport 9:3783–3789
Skrbic R, Igic R (2009) Seven decades of angiotensin (1939–2009). Peptides 30:1945–1950. doi:10.1016/j.peptides.2009.07.003
Stegbauer J, Vonend O, Habbel S, Quack I, Sellin L, Gross V, Rump LC (2005) Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice. J Hypertens 23:1691–1698
Takahasi K, Bardhan S, Kambayashi Y, Shirai H, Inagami T (1994) Protein tyrosine phosphatase inhibition by angiotensin II in rat pheochromocytoma cells through type 2 receptor, AT2. Biochem Biophys Res Commun 198:60–66. doi:10.1006/bbrc.1994.1009
Tamura M, Wanaka Y, Landon EJ, Inagami T (1999) Intracellular sodium modulates the expression of angiotensin II subtype 2 receptor in PC12 W cells. Hypertension 33:626–632. doi:10.1161/01.HYP.33.2.626
Tanabe A, Naruse M, Arai K, Naruse K, Yoshimoto T, Seki T, Imaki T, Miyazaki H, Zeng ZP, Demura R, Demura H (1998a) Gene expression and roles of angiotensin II type 1 and type 2 receptors in human adrenals. Horm Metab Res 30:490–495. doi:10.1055/s-2007-978918
Tanabe A, Naruse M, Arai K, Naruse K, Yoshimoto T, Seki T, Imaki T, Kobayashi M, Miyazaki H, Demura H (1998b) Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells. J Endocrinol Investig 21:668–672. doi:10.1007/BF03350796
Tao H, Rui C, Zheng J, Tang J, Wu L, Shi A, Chen N, He R, Wu C, Li J, Yin X, Zhang P, Zhu Z, Tao J, Xiao J, Mao C, Xu Z (2013) Angiotensin II-mediated vascular changes in aged offspring rats exposed to perinatal nicotine. Peptides 44:111–119. doi:10.1016/j.peptides.2013.02.019
Tjurmina OA, Armando I, Saavedra JM, Goldstein DS, Murphy DL (2002) Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology 143:4520–4526. doi:10.1210/en.2002-220416
Tjurmina OA, Armando I, Saavedra JM, Li Q, Murphy DL (2004) Life-long serotonin reuptake deficiency results in complex alterations in adrenomedullary responses to stress. Ann N Y Acad Sci 1018:99–104. doi:10.1196/annals.1296.011
Tota B, Angelone T, Cerra MC (2014) The surging role of Chromogranin A in cardiovascular homeostasis. Front Chem 2:64. doi:10.3389/fchem.2014.00064
Tsutsumi K, Saavedra JM (1991a) Increased dithiothreitol-insensitive, type 2 angiotensin II receptors in selected brain areas of young rats. Cell Mol Neurobiol 11:295–299
Tsutsumi K, Saavedra JM (1991b) Quantitative autoradiography reveals different angiotensin II receptor subtypes in selected rat brain nuclei. J Neurochem 56:348–351. doi:10.1111/j.1471-4159.1991.tb02602.x
Tsutsumi K, Saavedra JM (1991c) Differential development of angiotensin II receptor subtypes in the rat brain. Endocrinology 128:630–632. doi:10.1210/endo-128-1-630
Tsutsumi K, Saavedra JM (1991d) Characterization of AT2 angiotensin II receptors in rat anterior cerebral arteries. Am J Physiol 261:H667–H670
Tsutsumi K, Saavedra JM (1991e) Angiotensin-II receptor subtypes in median eminence and basal forebrain areas involved in regulation of pituitary function. Endocrinology 129:3001–3008. doi:10.1210/endo-129-6-3001
Tsutsumi K, Zorad S, Saavedra JM (1992) The AT2 subtype of the angiotensin II receptors has differential sensitivity to dithiothreitol in specific brain nuclei of young rats. Eur J Pharmacol 226:169–173
Tsuzuki S, Ichiki T, Nakakubo H, Kitami Y, Guo DF, Shirai H, Inagami T (1994) Molecular cloning and expression of the gene encoding human angiotensin II type 2 receptor. Biochem Biophys Res Commun 200:1449–1454. doi:10.1006/bbrc.1994.1613
VanAtten MK, Ensinger CL, Chiu AT, McCall DE, Nguyen TT, Wexler RR, Timmermans PB (1993) A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site. J Med Chem 36:3985–3992
Verdonk K, Durik M, Abd-Alla N, Batenburg WW, van den Bogaerdt AJ, van Veghel R, Roks AJ, Danser AH, van Esch JH (2012) Compound 21 induces vasorelaxation via an endothelium- and angiotensin II type 2 receptor-independent mechanism. Hypertension 60:722–729. doi:10.1161/HYPERTENSIONAHA.112
Villapol S, Saavedra JM (2015) Neuroprotective effects of angiotensin receptor blockers. Am J Hypertens 28:289–299. doi:10.1093/ajh/hpu197
Viswanathan M, de Oliveira AM, Correa FM, Saavedra JM (1994a) Expression of a novel non-angiotensin II [125I]CGP 42112 binding site in healing wounds of the rat brain. Brain Res 658:265–270. doi:10.1016/S0006-8993(09)90035-X
Viswanathan M, de Oliveira AM, Wu RM, Chiueh CC, Saavedra JM (1994b) [125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP +)-induced brain injury. Cell Mol Neurobiol 14:99–104
Volpe M, Gigante B, Enea I, Porcellini A, Russo R, Lee MA, Magri P, Condorelli G, Savoia C, Lindpaintner K, Rubattu S (1997) Role of tissue renin in the regulation of aldosterone biosynthesis in the adrenal cortex of nephrectomized rats. Circ Res 81:857–864. doi:10.1161/01.RES.81.5.857
Wang DH, Qiu J, Hu Z (1998) Differential regulation of angiotensin II receptor subtypes in the adrenal gland: role of aldosterone. Hypertension 32:65–70. doi:10.1161/01.HYP.32.1.65
Wang JM, Slembrouck D, Tan J, Arckens L, Leenen FH, Courtoy PJ, De Potter WP (2002) Presence of cellular renin-angiotensin system in chromaffin cells of bovine adrenal medulla. Am J Physiol Heart Circ Physiol 283:H1811–H1818. doi:10.1152/ajpheart.01092.2001
Watanabe T, Hashimoto M, Okuyama S, Inagami T, Nakamura S (1999) Effects of targeted disruption of the mouse angiotensin II type 2 receptor gene on stress-induced hyperthermia. J Physiol 515:881–885. doi:10.1111/j.1469-7793.1999.881ab.x
Whitebread SE, Taylor V, Bottari SP, Kamber B, de Gasparo M (1991) Radioiodinated CGP 42112A: a novel high affinity and highly selective ligand for the characterization of angiotensin AT2 receptors. Biochem Biophys Res Commun 181:1365–1371
Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F (2002) Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney Int 61:1986–1995. doi:10.1046/j.1523-1755.2002.00365.x
Wolf G, Schroeder R, Stahl RA (2004) Angiotensin II induces hypoxia-inducible factor-1 alpha in PC 12 cells through a posttranscriptional mechanism: role of AT2 receptors. Am J Nephrol 24:415–421. doi:10.1159/000080086
Wong PC, Hart SD, Zaspel AM, Chiu AT, Ardecky RJ, Smith RD, Timmermans PB (1990) Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: duP 753 (AII-1) and PD123177 (AII-2). J Pharmacol Exp Ther 255:584–592
Worck RH, Frandsen E, Ibsen H, Petersen JS (1998) AT1 and AT2 receptor blockade and epinephrine release during insulin-induced hypoglycemia. Hypertension 31:384–390. doi:10.1161/01.HYP.31.1.384
Xu P, Sriramula S, Lazartigues E (2011) ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. Am J Physiol Regul Integr Comp Physiol 300:R804–R817. doi:10.1152/ajpregu.00222.2010
Yiu AK, Wong PF, Yeung SY, Lam SM, Luk SK, Cheung WT (1997) Immunohistochemical localization of type-II (AT2) angiotensin receptors with a polyclonal antibody against a peptide from the C-terminal tail. Regul Pept 70:15–21. doi:10.1016/S0167-0115(97)00010-4
Zhang S, Morrison JL, Gill A, Rattanatray L, MacLaughlin SM, Kleemann D, Walker SK, McMillen IC (2013) Dietary restriction in the periconceptional period in normal-weight or obese ewes results in increased abundance of angiotensin-converting enzyme (ACE) and angiotensin type 1 receptor (AT1R) in the absence of changes in ACE or AT1R methylation in the adrenal of the offspring. Reproduction 146:443–454. doi:10.1530/REP-13-0219
Zhao Y, Foryst-Ludwig A, Bruemmer D, Culman J, Bader M, Unger T, Kintscher U (2005) Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12 W cells via angiotensin type 2 receptor activation. J Neurochem 94:1395–1401. doi:10.1111/j.1471-4159.2005.03275.x
Zhuo J, Song K, Abdelrahman A, Mendelsohn FA (1994) Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography. Clin Exp Pharmacol Physiol 21:557–567. doi:10.1111/j.1440-1681.1994.tb02555.x
Funding
The authors have not received any funding to prepare this review manuscript.
Author information
Authors and Affiliations
Contributions
JMS and IA have contributed equally to the selection of the review’s topic and the organization, writing, and final revision of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Saavedra, J.M., Armando, I. Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli. Cell Mol Neurobiol 38, 85–108 (2018). https://doi.org/10.1007/s10571-017-0533-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-017-0533-x